Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-028149

Director acquired 57,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HEIDEN WILLIAM K Director 2023-05-31 Grant or award +57,000 109,000 D
Derivatives
HEIDEN WILLIAM K Director 2023-05-31 Grant or award · Non-Qualified Stock Option (Right to Buy) +79,500 79,500 D
Loading xslF345X04/form4.xml…